Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130,255,320
-
Total 13F shares
-
24,830,644
-
Share change
-
+2,863,828
-
Total reported value
-
$57,358,129
-
Put/Call ratio
-
728%
-
Price per share
-
$2.31
-
Number of holders
-
73
-
Value change
-
-$5,602,917
-
Number of buys
-
50
-
Number of sells
-
33
Institutional Holders of Ovid Therapeutics Inc. - COMMON STOCK (OVID) as of Q4 2020
As of 31 Dec 2020,
Ovid Therapeutics Inc. - COMMON STOCK (OVID) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,830,644 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Vivo Capital, LLC, UBS Group AG, BAKER BROS. ADVISORS LP, CHI Advisors LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and AXA S.A..
This page lists
73
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.